Viewpoints » Visby to Exhibit at the 28th AACC International CPOCT Symposium

09/08/2022Viewpoint

Visby to Exhibit at the 28th AACC International CPOCT Symposium

Come see Visby Medical at the 28th AACC International CPOCT Symposium, a gathering designed to meet the needs of laboratory professionals.

Visby to Exhibit at the 28th AACC International CPOCT Symposium

28th AACC International CPOCT Symposium

Meeting Evolving Patient Needs Using Point-of-Care Testing

September 21-23, 2022
Doubletree by Hilton Montreal
1255 Jeanne Mance St
Montreal, Quebec, Canada

This symposium is designed to meet the needs of laboratory professionals overseeing and/or carrying out point-of-care testing, clinical laboratory physicians, supervisors, managers, regulatory personnel, and other laboratory professionals interested in advances in point-of-care testing.

Come see Visby Medical at the 28th AACC International CPOCT Symposium, a gathering designed to meet the needs of laboratory professionals.

Visit our booth to hold our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas.

Register

Learn more about the Visby Medical Sexual Health Test

Read more articles & insights

05/11/2023Viewpoint

Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Read More
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

03/14/2023Press Release

Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.

Read More
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

01/03/2023Press Release

Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings

Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.

Read More
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings

09/15/2022Viewpoint

Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby

Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.

Read More
Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby